Boston Scientific Corp. Stock Sheds 3.4%, Underperforms Peers
Dow Jones2026/08/26 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. shed 3.4% to $48.17 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,675.70 and the Dow Jones Industrial Average falling 0.2% to 53,463.88.
Boston Scientific Corp. closed 56.0% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 1.7% to $114.10, Medtronic PLC rose 1.0% to $92.02, and Stryker Corp. fell 0.28% to $329.67.
Trading volume totaled 36.0 million, compared to the 50-day average of 20.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 26, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Electronics (Thailand)'s Recent Selloff Presents Accumulation Opportunity -- Market Talk
The data center construction boom may increase inflationary pressure, and the Reserve Bank of Australia may be forced to maintain high interest rates.
The data center construction boom in Australia may lead to demand exceeding the supply capacity of the economy, which could push up inflation and force the Reserve Bank of Australia to maintain higher interest rates.
Reliance step-down unit Roptonal dissolves in Cyprus with effect Aug. 18, 2026
Crypto prices
More
